Seitaro Terakura

3.0k total citations
104 papers, 1.7k citations indexed

About

Seitaro Terakura is a scholar working on Hematology, Immunology and Oncology. According to data from OpenAlex, Seitaro Terakura has authored 104 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 60 papers in Hematology, 47 papers in Immunology and 45 papers in Oncology. Recurrent topics in Seitaro Terakura's work include Hematopoietic Stem Cell Transplantation (56 papers), CAR-T cell therapy research (29 papers) and Immune Cell Function and Interaction (29 papers). Seitaro Terakura is often cited by papers focused on Hematopoietic Stem Cell Transplantation (56 papers), CAR-T cell therapy research (29 papers) and Immune Cell Function and Interaction (29 papers). Seitaro Terakura collaborates with scholars based in Japan, United States and Thailand. Seitaro Terakura's co-authors include Makoto Murata, Tetsuya Nishida, Hitoshi Kiyoi, Tomoki Naoe, Tatsunori Goto, Keisuke Watanabe, Koichi Miyamura, Stanley R. Riddell, Yoshiko Atsuta and Ryo Hanajiri and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Seitaro Terakura

96 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Seitaro Terakura Japan 22 864 746 624 364 264 104 1.7k
Rammurti T. Kamble United States 17 1.4k 1.6× 632 0.8× 514 0.8× 545 1.5× 508 1.9× 66 2.1k
Siddhartha Ganguly United States 21 784 0.9× 617 0.8× 209 0.3× 618 1.7× 103 0.4× 138 1.6k
Christoph Faul Germany 22 1.3k 1.5× 1.1k 1.5× 608 1.0× 278 0.8× 157 0.6× 82 2.5k
Abhinav Deol United States 18 582 0.7× 631 0.8× 281 0.5× 294 0.8× 78 0.3× 114 1.1k
Alison R. Sehgal United States 13 633 0.7× 326 0.4× 227 0.4× 373 1.0× 136 0.5× 52 1.1k
Patrick Schlegel Germany 17 529 0.6× 329 0.4× 498 0.8× 200 0.5× 102 0.4× 44 1.1k
Elena Mead United States 10 2.1k 2.5× 242 0.3× 524 0.8× 556 1.5× 597 2.3× 25 2.4k
Zaid Al‐Kadhimi United States 18 540 0.6× 425 0.6× 337 0.5× 182 0.5× 113 0.4× 84 1.0k
Quanshun Wang China 10 755 0.9× 176 0.2× 245 0.4× 285 0.8× 241 0.9× 63 1.0k
Francis Ayuk Germany 37 1.2k 1.3× 2.9k 3.9× 1000 1.6× 827 2.3× 173 0.7× 164 3.9k

Countries citing papers authored by Seitaro Terakura

Since Specialization
Citations

This map shows the geographic impact of Seitaro Terakura's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Seitaro Terakura with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Seitaro Terakura more than expected).

Fields of papers citing papers by Seitaro Terakura

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Seitaro Terakura. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Seitaro Terakura. The network helps show where Seitaro Terakura may publish in the future.

Co-authorship network of co-authors of Seitaro Terakura

This figure shows the co-authorship network connecting the top 25 collaborators of Seitaro Terakura. A scholar is included among the top collaborators of Seitaro Terakura based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Seitaro Terakura. Seitaro Terakura is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Terakura, Seitaro, Yuki Takeuchi, Takahiko Sato, et al.. (2025). Adjustment of low-dose ATG exposure improves outcomes in allogeneic hematopoietic stem cell transplantation: a prospective multicenter study. Cytotherapy. 27(8). 962–972.
2.
Ushijima, Yoko, Yuichi Ishikawa, Naomi Kawashima, et al.. (2024). Initiating-clone analysis in patients with acute myeloid leukemia secondary to essential thrombocythemia. Scientific Reports. 14(1). 15906–15906.
3.
Tamaki, Masaharu, Yu Akahoshi, Yoshihiro Inamoto, et al.. (2024). Associations between acute and chronic graft-versus-host disease. Blood Advances. 8(16). 4250–4261.
4.
Shimomura, Yoshimitsu, Tetsuhisa Kitamura, Makoto Murata, et al.. (2024). Impact of Center Volume on Chronic Graft Versus Host Disease in Patients With Allogeneic Stem Cell Transplantation. Transplantation and Cellular Therapy. 30(3). 326.e1–326.e14. 2 indexed citations
5.
Terakura, Seitaro, Yusuke Okuno, Yoshitaka Sato, et al.. (2024). Cullin-5 deficiency promotes chimeric antigen receptor T cell effector functions potentially via the modulation of JAK/STAT signaling pathway. Nature Communications. 15(1). 10376–10376. 7 indexed citations
6.
Terakura, Seitaro, Shingo Okuno, Ryo Hanajiri, et al.. (2023). Dual CAR-T Cells Targeting CD19 and CD37 Are Effective in Target Antigen Loss B-cell Tumor Models. Molecular Cancer Therapeutics. 23(3). 381–393. 9 indexed citations
7.
Saetang, Jirakrit, et al.. (2023). Impact of Glycine-Serine Linker on Target Antigen Binding and Subsequent CD37CAR-T Performance. Blood. 142(Supplement 1). 3623–3623. 1 indexed citations
8.
Shimomura, Yoshimitsu, Sho Komukai, Tetsuhisa Kitamura, et al.. (2023). Effect of graft-versus-host disease on outcomes of HLA-haploidentical peripheral blood transplantation using post-transplant cyclophophamide. Bone Marrow Transplantation. 59(1). 66–75. 2 indexed citations
9.
Terakura, Seitaro, Hidetsugu Fujigaki, Akinao Okamoto, et al.. (2023). Antibody response after third dose of COVID-19 mRNA vaccination in allogeneic hematopoietic stem cell transplant recipients is comparable to that in healthy counterparts. International Journal of Hematology. 118(4). 462–471. 1 indexed citations
10.
Murata, Makoto, Seitaro Terakura, Atsushi Wake, et al.. (2021). Off-the-shelf bone marrow-derived mesenchymal stem cell treatment for acute graft-versus-host disease: real-world evidence. Bone Marrow Transplantation. 56(10). 2355–2366. 33 indexed citations
11.
Shiratori, Souichi, Junichi Sugita, Shigeo Fuji, et al.. (2021). Low-dose antithymocyte globulin inhibits chronic graft-versus-host disease in peripheral blood stem cell transplantation from unrelated donors. Bone Marrow Transplantation. 56(9). 2231–2240. 5 indexed citations
12.
13.
Terakura, Seitaro, Kazuteru Ohashi, Takahiro Fukuda, et al.. (2019). Impacts of thymoglobulin in patients with acute leukemia in remission undergoing allogeneic HSCT from different donors. Blood Advances. 3(2). 105–115. 16 indexed citations
14.
Miyao, Kotaro, Seitaro Terakura, Shingo Okuno, et al.. (2018). Introduction of Genetically Modified CD3ζ Improves Proliferation and Persistence of Antigen-Specific CTLs. Cancer Immunology Research. 6(6). 733–744. 16 indexed citations
15.
Koyama, Daisuke, Makoto Murata, Ryo Hanajiri, et al.. (2017). Quantitative Assessment of TCR Repertoire and Allo-Reactivity of Human Acute Gvhd Tissue-Infiltrating T Cells. Blood. 130. 1982. 2 indexed citations
16.
Koyama, Daisuke, Makoto Murata, Ryo Hanajiri, et al.. (2017). High incidence of extensive chronic graft-versus-host disease in patients with the REG3A rs7588571 non-GG genotype. PLoS ONE. 12(9). e0185213–e0185213. 3 indexed citations
17.
Sakemura, Reona, Seitaro Terakura, Keisuke Watanabe, et al.. (2016). A Tet-On Inducible System for Controlling CD19-Chimeric Antigen Receptor Expression upon Drug Administration. Cancer Immunology Research. 4(8). 658–668. 129 indexed citations
18.
Goto, Tatsunori, Tetsuya Nishida, Kotaro Miyao, et al.. (2016). Programmed Death-Ligand 1 on Antigen-presenting Cells Facilitates the Induction of Antigen-specific Cytotoxic T Lymphocytes: Application to Adoptive T-Cell Immunotherapy. Journal of Immunotherapy. 39(8). 306–315. 13 indexed citations
19.
Sugimoto, Kyoko, Makoto Murata, Seitaro Terakura, & Tomoki Naoe. (2009). CTL Clones Isolated from an HLA-Cw-Mismatched Bone Marrow Transplant Recipient with Acute Graft-Versus-Host Disease. The Journal of Immunology. 183(9). 5991–5998. 9 indexed citations
20.
Inamoto, Yoshihiro, Koichi Miyamura, Seitaro Terakura, et al.. (2006). Stable Engraftment after a Conditioning Regimen with Fludarabine and Melphalan for Bone Marrow Transplantation from an Unrelated Donor. International Journal of Hematology. 83(4). 356–362. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rammurti T. Kamble Breakdown of academic impact, for papers by Siddhartha Ganguly Breakdown of academic impact, for papers by Christoph Faul Breakdown of academic impact, for papers by Abhinav Deol Breakdown of academic impact, for papers by Alison R. Sehgal Breakdown of academic impact, for papers by Patrick Schlegel Breakdown of academic impact, for papers by Elena Mead Breakdown of academic impact, for papers by Zaid Al‐Kadhimi Breakdown of academic impact, for papers by Quanshun Wang Breakdown of academic impact, for papers by Francis Ayuk
Rankless by CCL
2026